title: [Venous forms of the inborn vascular malformations of the lower extremities. Diagnosis and surgical treatment].
abstract: Pathogenetically substantiated approach, using surgical, laser and echosclerosing methods, was applied for improvement of the treatment results in patients, suffering venous forms of the inborn vascular malformations of the lower extremities. The results of examination and treatment in 2006-2009 period were analyzed in 98 patients. The stem malformations with superficial venous system affection was diagnosed in 59 (60.2%) patients, the same with a deep venous system affection--in 27 (27.6%), the extrastem affections--in 7 (7.1%) and the combined malformations--in 5 (5.1%). There was differential tactics of the surgical treatment used together with combination of original surgical procedures, newest laser methods and sclerotherapy, which have permitted to achieve satisfactory late results in 73 (74.5%) patients. Poor results in 25 (25.5%) patients were caused by the pathological process spread and proliferative activity of malformation, what was confirmed by immunohistochemical and morphological investigations data.
authors.forename: L M
authors.initials: LM
authors.lastname: Chernukha
authors.forename: A O
authors.initials: AO
authors.lastname: Huch
authors.forename: M O
authors.initials: MO
authors.lastname: Artemenko
authors.forename: I V
authors.initials: IV
authors.lastname: Al'tman
authors.forename: I V
authors.initials: IV
authors.lastname: Homoliako
authors.forename: T D
authors.initials: TD
authors.lastname: Zadorozhna
authors.forename: O I
authors.initials: OI
authors.lastname: Il'ïna
authors.forename: H H
authors.initials: HH
authors.lastname: Vlaĭkov
authors.forename: O V
authors.initials: OV
authors.lastname: Kashyrova
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D004730:Endothelium, Vascular / Q000378:metabolism / Q000473:pathology; D057510:Endovascular Procedures / Q000379:methods; D005260:Female; D006801:Humans; D017075:Laser Coagulation / Q000379:methods; D035002:Lower Extremity / Q000098:blood supply* / Q000000981:diagnostic imaging / Q000601:surgery; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000000981:diagnostic imaging / Q000473:pathology / Q000601:surgery; D018809:Proliferating Cell Nuclear Antigen / Q000096:biosynthesis; D012039:Regional Blood Flow / Q000502:physiology; D015911:Sclerotherapy / Q000379:methods; D016896:Treatment Outcome; D014463:Ultrasonography; D040301:Vascular Endothelial Growth Factor Receptor-2 / Q000096:biosynthesis; D054079:Vascular Malformations / Q000000981:diagnostic imaging / Q000473:pathology / Q000601:surgery; D014656:Vascular Surgical Procedures / Q000379:methods*; D014680:Veins / Q000002:abnormalities* / Q000000981:diagnostic imaging / Q000473:pathology / Q000601:surgery; D055815:Young Adult
chemical_list: D018809:Proliferating Cell Nuclear Antigen; D040301:Vascular Endothelial Growth Factor Receptor-2